Inclusive of all taxes
ES-PROZOLE 40 TAB by Dr Precision is a high-quality, enteric-coated proton pump inhibitor tablet containing 40 mg of Esomeprazole. Specifically designed for effective management of gastroesophageal reflux disease (GERD), erosive esophagitis, peptic ulcers, Zollinger-Ellison syndrome, and NSAID-induced ulcer prevention, this formulation ensures optimal acid suppression and promotes gastric mucosa healing. Manufactured under strict WHO-GMP compliant processes by BluepillExpress, ES-PROZOLE 40 delivers enhanced bioavailability through its delayed-release mechanism that targets intestinal absorption. This product is ideal for pharmaceutical distributors, hospital tenders, healthcare institutions, and pharma exporters looking for dependable and high-standard gastroenterological medicines in regulated and semi-regulated markets. With its robust formulation and consistent batch quality assurance, ES-PROZOLE 40 TAB provides exceptional clinical efficacy against acid-related gastrointestinal disorders.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Esomeprazole 40 mg |
| Dosage Form | Enteric-coated tablet |
| Therapeutic Class | Proton Pump Inhibitor (PPI) |
| Indications | GERD, erosive esophagitis, peptic ulcers, Zollinger-Ellison syndrome, NSAID-induced ulcer prophylaxis |
| Mechanism of Action | Irreversibly inhibits H+/K+ ATPase enzyme in gastric parietal cells, suppressing stomach acid secretion |
| Bioavailability | Approximately 90% after repeated dosing |
| Onset of Action | Within 1 hour |
| Manufacturing Standards | WHO-GMP certified, GMP-compliant formulation |
| Shelf Life & Stability | Optimized for long shelf life with consistent batch quality |
| Target Market | Pharma exporters, hospital tenders, healthcare distributors |
| Attributes | Description |
|---|---|
| Strength | 40 mg Esomeprazole |
| Form | Tablet |
| Release Mechanism | Delayed-release enteric coating |
| Standard Dose | 1 tablet once daily |
| Pharmacokinetics | Half-life - 1.3 hours; Metabolism - hepatic via CYP2C19 and CYP3A4; Excretion - renal and biliary |
| Packaging | Available for bulk packaging and customized client orders |
| Label | Dr Precision |
| Manufactured By | BluepillExpress |
| Therapeutic Use Duration | Typically 4-8 weeks for GERD and erosive esophagitis |
| Storage Recommendations | Store in a cool, dry place away from direct sunlight |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
ES-PROZOLE 40 TAB is manufactured under stringent WHO-GMP certified conditions, ensuring consistent quality and pharmaceutical standards batch after batch. Its enteric-coated delayed-release design guarantees optimal absorption and acid suppression, making it highly effective for clinical use. This reliability and quality control make it ideal for large scale institutional supply and export in regulated and semi-regulated markets.
The enteric-coated delayed-release tablet is designed to bypass the acidic environment of the stomach and dissolve in the intestines. This targeted release protects Esomeprazole from degradation in gastric acid, improves its bioavailability (~90%), and thereby enhances acid suppression efficacy.
Yes, ES-PROZOLE 40 is indicated as a component of triple therapy regimens for Helicobacter pylori eradication, often combined with antibiotics, to effectively reduce gastric acidity and improve the healing of ulcers caused by H. pylori infection.
The standard dosage is one 40 mg tablet once daily, preferably taken at least one hour before meals. For GERD and erosive esophagitis, treatment typically ranges between 4 to 8 weeks, with adjustments based on clinical evaluation.
Yes, ES-PROZOLE 40 TAB is clinically indicated for prophylaxis against NSAID-associated gastric ulcers by reducing gastric acid secretion and protecting the gastric mucosa during NSAID therapy.
Country Of Origin: India
ES-PROZOLE 40 TAB is a high-quality proton pump inhibitor (PPI) formulation containing Esomeprazole 40 mg, clinically indicated for the management of acid reflux, GERD, peptic ulcers, and erosive esophagitis. Developed and manufactured by BluepillExpress, this enteric-coated tablet delivers optimal acid suppression, promotes healing of gastric mucosa, and relieves heartburn and acid-related symptoms. ES-PROZOLE 40 is a dependable solution for third-party manufacturing, institutional supply, or pharma export across regulated and semi-regulated markets.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
ES-PROZOLE 40 TAB, from the expert manufacturing house of BluepillExpress, is a therapeutic-grade oral formulation of Esomeprazole, the S-isomer of omeprazole. It belongs to the class of proton pump inhibitors (PPIs) and provides effective and long-lasting suppression of gastric acid secretion by selectively blocking the H+/K+ ATPase enzyme system in gastric parietal cells.
Esomeprazole 40 mg is widely prescribed for the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, peptic ulcer disease, Zollinger-Ellison syndrome, and for NSAID-induced ulcer prophylaxis. Its delayed-release design ensures targeted action in the intestines, enhancing absorption and bioavailability while minimizing gastric degradation.
Backed by WHO-GMP certified production facilities, ES-PROZOLE 40 TAB guarantees high pharmaceutical standards, consistency in every batch, and optimal shelf stability. This product is ideal for pharmaceutical distributors, hospital tenders, healthcare chains, and international buyers seeking quality-assured gastroenterological medicines.
✅ Therapeutic Uses
Gastroesophageal Reflux Disease (GERD)
Erosive Esophagitis
Peptic Ulcer Disease (PUD)
Helicobacter pylori eradication regimens (as part of triple therapy)
NSAID-associated gastric ulcers and prevention
Zollinger-Ellison Syndrome
Functional Dyspepsia
✅ Mechanism of Action
Esomeprazole irreversibly inhibits the H+/K+ ATPase (proton pump) on gastric parietal cells, the final step of acid secretion. This leads to prolonged reduction of stomach acid production and provides symptomatic relief from acid reflux and heartburn while promoting healing of gastric mucosa.
✅ Dosage & Administration
Standard dose: 1 tablet (40 mg) once daily
In GERD and erosive esophagitis: 4 to 8 weeks therapy recommended
Take at least 1 hour before meals for best effect
Dosage may be adjusted based on severity and clinical judgment
✅ Pharmacokinetics
Bioavailability: Approximately 90% after repeated doses
Onset of Action: Within 1 hour
Half-life: 1.3 hours
Metabolism: Hepatic via CYP2C19 and CYP3A4
Excretion: Renal and biliary
Inclusive of all taxes
You Save: 0
Surat , India
Manufacturer, Contractor, Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler, Startup
GST- 24abdfb4194j1ze
